3 weeks Positive Trial Data on Evolut TAVR Likely to Support MDT Stock Zacks
At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.
X